首页> 外文期刊>Proceedings / Baylor University Medical Center >Evaluation of medication compliance for secondary prevention of acute coronary syndrome
【24h】

Evaluation of medication compliance for secondary prevention of acute coronary syndrome

机译:急性冠脉综合征二级预防药物依从性评估

获取原文
获取外文期刊封面目录资料

摘要

To prevent recurrence of acute coronary syndrome (ACS), national practice guidelines recommend use of five-drug combination therapy. Our study assessed the proportion of patients discharged on all five medications following ACS and determined reasons for nonadherence. A retrospective, single-center chart review was conducted at a tertiary academic medical center. Patients 18 years and older who were admitted to the cardiac care unit with a diagnosis of ACS between January 2013 and January 2015 were included. Overall, 200 patients were screened and 155 were included in the study. Half of the patients received all guideline-recommended classes of pharmacological agents at discharge. The other half—78 patients—did not receive the five-drug combination, of whom 48 (62%) had reasons documented for nonadherence. Our study’s findings suggest that rates of adherence need to improve given the clear benefits of these medications
机译:为防止急性冠状动脉综合征(ACS)的复发,国家实践指南建议使用五药联合疗法。我们的研究评估了ACS后所有五种药物出院的患者比例,并确定了不依从的原因。在三级学术医学中心进行了回顾性单中心图表审查。纳入了2013年1月至2015年1月之间入院诊断为ACS的18岁以上患者。总体上,对200例患者进行了筛查,其中155例纳入研究。一半的患者出院时接受了所有指南推荐的药物治疗。另一半(78例患者)未接受五药联用,其中48例(62%)有不依从的证据。我们的研究结果表明,鉴于这些药物的明显益处,需要提高依从性

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号